Gubra A/S Sustainability Reports
Gubra A/S is a specialized biotechnology company that provides preclinical contract research services (CRO) and conducts advanced peptide-based drug discovery. The company focuses heavily on metabolic and fibrotic diseases such as obesity, diabetes, and MASH.
Sector: Professional & technical services
Country: Denmark
Exchange: Nasdaq Copenhagen
ISIN: DK0062266474
9 reports from 2019 to 2025